CD86 and hepatocellular carcinoma: Moreover, less costimulatory signals such as CD80/CD86 are present on the membrane of antigen-presenting cells (13), while more inhibitory checkpoint signals such as CTLA-4 and PD-L1 are abnormally expressed on the surface of HCC cells.